logo
Vipul Ltd.
18 Nov 2025
Parmax Pharma Ltd - 540359 - Results-Delay in Financial Results
BSE India
The Board meeting for approval of Financial statements was rescheduled initially on November 15, 2025 and thenafter on today i.e. November 17, 2025. The Board has approved the unaudited financial results for quarter and half year ended on September 30, 2025